{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:55:34Z","timestamp":1766037334270,"version":"3.48.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,17]]},"DOI":"10.7759\/cureus.99503","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:52:11Z","timestamp":1766037131000},"source":"Crossref","is-referenced-by-count":0,"title":["Arrhythmogenic Implications of Inflammatory Bowel Disease: Its Mechanisms and Treatment Effects"],"prefix":"10.7759","author":[{"given":"Enayat S","family":"Almasri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabish  W","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama M","family":"Almasri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gizalla","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela A","family":"Benoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayathri","family":"Pradeep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mais O","family":"Abu-Sa'da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Alaboud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rand N","family":"Fatayerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raqshan W","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003542","article-title":"Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years","volume":"138","author":"Wan J","year":"2025","unstructured":"Wan J, Zhou J, Wang Z, Liu D, Zhang H, Xie S, Wu K. Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years. Chin Med J (Engl). 2025, 138:763-76. 10.1097\/CM9.0000000000003542","journal-title":"Chin Med J (Engl)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12350","article-title":"The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries","volume":"10","author":"Aniwan S","year":"2022","unstructured":"Aniwan S, Santiago P, Loftus EV Jr, Park SH. The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries. United European Gastroenterol J. 2022, 10:1063-76. 10.1002\/ueg2.12350","journal-title":"United European Gastroenterol J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-025-01063-x","article-title":"Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response","volume":"22","author":"Solitano V","year":"2025","unstructured":"Solitano V, Bernstein CN, Dotan I, et al.. Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response. Nat Rev Gastroenterol Hepatol. 2025, 22:438-52. 10.1038\/s41575-025-01063-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.06.049","article-title":"The cost of inflammatory bowel disease care: how to make it sustainable","volume":"23","author":"Burisch J","year":"2025","unstructured":"Burisch J, Claytor J, Hernandez I, Hou JK, Kaplan GG. The cost of inflammatory bowel disease care: how to make it sustainable. Clin Gastroenterol Hepatol. 2025, 23:386-95. 10.1016\/j.cgh.2024.06.049","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ani12020145","article-title":"Integrity of the intestinal barrier: the involvement of epithelial cells and microbiota-a mutual relationship","volume":"12","author":"Giery\u0144ska M","year":"2022","unstructured":"Giery\u0144ska M, Szulc-D\u0105browska L, Struzik J, Mielcarska MB, Gregorczyk-Zboroch KP. Integrity of the intestinal barrier: the involvement of epithelial cells and microbiota-a mutual relationship. Animals (Basel). 2022, 12:145. 10.3390\/ani12020145","journal-title":"Animals (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.08.012","article-title":"Inflammatory bowel disease and cardiovascular diseases","volume":"135","author":"Chen B","year":"2022","unstructured":"Chen B, Collen LV, Mowat C, et al.. Inflammatory bowel disease and cardiovascular diseases. Am J Med. 2022, 135:1453-60. 10.1016\/j.amjmed.2022.08.012","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai Z","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne). 2021, 8:765474. 10.3389\/fmed.2021.765474","journal-title":"Front Med (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?","volume":"30","author":"Bigeh A","year":"2020","unstructured":"Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?. Trends Cardiovasc Med. 2020, 30:463-9. 10.1016\/j.tcm.2019.10.001","journal-title":"Trends Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96111-6","article-title":"Ulcerative colitis increases the risk of atrioventricular block: evidence from a Mendelian randomized analysis","volume":"15","author":"Shu W","year":"2025","unstructured":"Shu W, Huang G. Ulcerative colitis increases the risk of atrioventricular block: evidence from a Mendelian randomized analysis. Sci Rep. 2025, 15:11873. 10.1038\/s41598-025-96111-6","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-097687","article-title":"Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada","volume":"15","author":"Narous M","year":"2025","unstructured":"Narous M, Nugent Z, Rabinovich-Nikitin I, Kirshenbaum L, Bernstein CN. Cardiac arrhythmia in patients with inflammatory bowel disease: a retrospective, population-based cohort study in Manitoba, Canada. BMJ Open. 2025, 15:e097687. 10.1136\/bmjopen-2024-097687","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004305","article-title":"Long-term risk of arrhythmias in patients with inflammatory bowel disease: a population-based, sibling-controlled cohort study","volume":"20","author":"Sun J","year":"2023","unstructured":"Sun J, Roelstraete B, Svennberg E, et al.. Long-term risk of arrhythmias in patients with inflammatory bowel disease: a population-based, sibling-controlled cohort study. PLoS Med. 2023, 20:e1004305. 10.1371\/journal.pmed.1004305","journal-title":"PLoS Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.04.031","article-title":"Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases","volume":"16","author":"Aniwan S","year":"2018","unstructured":"Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018, 16:1607-15. 10.1016\/j.cgh.2018.04.031","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-022-03001-0","article-title":"Effects of different doses of glucocorticoids on postoperative atrial fibrillation: a meta-analysis","volume":"23","author":"Zhou Z","year":"2023","unstructured":"Zhou Z, Long Y, He X, Li Y. Effects of different doses of glucocorticoids on postoperative atrial fibrillation: a meta-analysis. BMC Cardiovasc Disord. 2023, 23:16. 10.1186\/s12872-022-03001-0","journal-title":"BMC Cardiovasc Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2023.01.019","article-title":"Exposure to anti-TNF medications does not increase the risk of cardiac arrhythmia in inflammatory bowel disease: a population-based cohort study","volume":"2","author":"Larsen L","year":"2023","unstructured":"Larsen L, Olsen KD, Christensen HS, Allin KH, Jess T. Exposure to anti-TNF medications does not increase the risk of cardiac arrhythmia in inflammatory bowel disease: a population-based cohort study. Gastro Hep Adv. 2023, 2:478-9. 10.1016\/j.gastha.2023.01.019","journal-title":"Gastro Hep Adv"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27631-8","article-title":"Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database","volume":"13","author":"Nguyen LS","year":"2022","unstructured":"Nguyen LS, Cooper LT, Kerneis M, et al.. Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database. Nat Commun. 2022, 13:25. 10.1038\/s41467-021-27631-8","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.970597","article-title":"Analysis of clinical characteristics of mesalazine-induced cardiotoxicity","volume":"13","author":"Chen J","year":"2022","unstructured":"Chen J, Duan T, Fang W, Liu S, Wang C. Analysis of clinical characteristics of mesalazine-induced cardiotoxicity. Front Pharmacol. 2022, 13:970597. 10.3389\/fphar.2022.970597","journal-title":"Front Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025130","article-title":"Effects of corticosteroids on new-onset atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials","volume":"100","author":"Liu L","year":"2021","unstructured":"Liu L, Jing FY, Wang XW, Li LJ, Zhou RQ, Zhang C, Wu QC. Effects of corticosteroids on new-onset atrial fibrillation after cardiac surgery: a meta-analysis of randomized controlled trials. Medicine (Baltimore). 2021, 100:e25130. 10.1097\/MD.0000000000025130","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez M","year":"2020","unstructured":"Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med. 2020, 17:e1003432. 10.1371\/journal.pmed.1003432","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.14.1562","article-title":"Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial","volume":"297","author":"Halonen J","year":"2007","unstructured":"Halonen J, Halonen P, J\u00e4rvinen O, et al.. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA. 2007, 297:1562-7. 10.1001\/jama.297.14.1562","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-235","article-title":"Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD)","volume":"113","author":"Villanacci V","year":"2021","unstructured":"Villanacci V, Reggiani-Bonetti L, Salviato T, et al.. Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica. 2021, 113:39-53. 10.32074\/1591-951X-235","journal-title":"Pathologica"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4180-8","article-title":"Clinical activity and quality of life indices are valid across ulcerative colitis but not Crohn\u2019s disease phenotypes","volume":"61","author":"Taleban S","year":"2016","unstructured":"Taleban S, Stewart KO, Li DK, et al.. Clinical activity and quality of life indices are valid across ulcerative colitis but not Crohn\u2019s disease phenotypes. Dig Dis Sci. 2016, 61:2627-35. 10.1007\/s10620-016-4180-8","journal-title":"Dig Dis Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2014-100530","article-title":"Development and validation of a new disease severity index: the inflammatory bowel disease index (IBDEX)","volume":"6","author":"Alrubaiy L","year":"2015","unstructured":"Alrubaiy L, Dodds P, Hutchings HA, Russell IT, Watkins A, Williams JG. Development and validation of a new disease severity index: the inflammatory bowel disease index (IBDEX). Frontline Gastroenterol. 2015, 6:161-8. 10.1136\/flgastro-2014-100530","journal-title":"Frontline Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-022-01862-y","article-title":"A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation","volume":"57","author":"Kishi M","year":"2022","unstructured":"Kishi M, Hirai F, Takatsu N, et al.. A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation. J Gastroenterol. 2022, 57:246-66. 10.1007\/s00535-022-01862-y","journal-title":"J Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/138945012802429714","article-title":"Imaging of the colon in inflammatory bowel disease: ready for prime time?","volume":"13","author":"Ordas I","year":"2012","unstructured":"Ordas I, Rimola J, Rodriguez S, Gallego M, Ricart E, Panes J. Imaging of the colon in inflammatory bowel disease: ready for prime time?. Curr Drug Targets. 2012, 13:1252-60. 10.2174\/138945012802429714","journal-title":"Curr Drug Targets"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.73134","article-title":"The current role of imaging in the diagnosis of inflammatory bowel disease and detection of its complications: a systematic review","volume":"16","author":"Younis MY","year":"2024","unstructured":"Younis MY, Khan MU, Khan U, et al.. The current role of imaging in the diagnosis of inflammatory bowel disease and detection of its complications: a systematic review. Cureus. 2024, 16:e73134. 10.7759\/cureus.73134","journal-title":"Cureus"},{"key":"ref26","article-title":"Inflammatory Bowel Disease","author":"McDowell C","year":"2023","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot C","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018, 50:1-9. 10.1038\/s12276-018-0126-x","journal-title":"Exp Mol Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2018.16.1.26","article-title":"Immunological pathogenesis of inflammatory bowel disease","volume":"16","author":"Lee SH","year":"2018","unstructured":"Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018, 16:26-42. 10.5217\/ir.2018.16.1.26","journal-title":"Intest Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.12938\/bmfh.2015-019","article-title":"Paneth cell \u03b1-defensins and enteric microbiota in health and disease","volume":"35","author":"Nakamura K","year":"2016","unstructured":"Nakamura K, Sakuragi N, Takakuwa A, Ayabe T. Paneth cell \u03b1-defensins and enteric microbiota in health and disease. Biosci Microbiota Food Health. 2016, 35:57-67. 10.12938\/bmfh.2015-019","journal-title":"Biosci Microbiota Food Health"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/nrm4024","article-title":"Autophagy at the crossroads of catabolism and anabolism","volume":"16","author":"Kaur J","year":"2015","unstructured":"Kaur J, Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat Rev Mol Cell Biol. 2015, 16:461-72. 10.1038\/nrm4024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X16644242","article-title":"The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions","volume":"9","author":"Vindigni SM","year":"2016","unstructured":"Vindigni SM, Zisman TL, Suskind DL, Damman CJ. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions. Therap Adv Gastroenterol. 2016, 9:606-25. 10.1177\/1756283X16644242","journal-title":"Therap Adv Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nri3684","article-title":"The mycobiota: interactions between commensal fungi and the host immune system","volume":"14","author":"Underhill DM","year":"2014","unstructured":"Underhill DM, Iliev ID. The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014, 14:405-16. 10.1038\/nri3684","journal-title":"Nat Rev Immunol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S492079","article-title":"Dissecting innate and adaptive immunity in inflammatory bowel disease: immune compartmentalization, microbiota crosstalk, and emerging therapies","volume":"17","author":"Yue N","year":"2024","unstructured":"Yue N, Hu P, Tian C, et al.. Dissecting innate and adaptive immunity in inflammatory bowel disease: immune compartmentalization, microbiota crosstalk, and emerging therapies. J Inflamm Res. 2024, 17:9987-10014. 10.2147\/JIR.S492079","journal-title":"J Inflamm Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern recognition receptors: function, regulation and therapeutic potential","volume":"10","author":"Chen R","year":"2025","unstructured":"Chen R, Zou J, Chen J, Zhong X, Kang R, Tang D. Pattern recognition receptors: function, regulation and therapeutic potential. Signal Transduct Target Ther. 2025, 10:216. 10.1038\/s41392-025-02264-1","journal-title":"Signal Transduct Target Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39134","article-title":"Dendritic cells in intestinal homeostasis and disease","volume":"119","author":"Rescigno M","year":"2009","unstructured":"Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest. 2009, 119:2441-50. 10.1172\/JCI39134","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjae082","article-title":"Epidemiology of inflammatory bowel disease across the ages in the era of advanced therapies","volume":"18","author":"Caron B","year":"2024","unstructured":"Caron B, Honap S, Peyrin-Biroulet L. Epidemiology of inflammatory bowel disease across the ages in the era of advanced therapies. J Crohns Colitis. 2024, 18:ii3-ii15. 10.1093\/ecco-jcc\/jjae082","journal-title":"J Crohns Colitis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2020.00008","article-title":"The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease","volume":"19","author":"Nicolaides S","year":"2021","unstructured":"Nicolaides S, Vasudevan A, Long T, van Langenberg D. The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease. Intest Res. 2021, 19:158-70. 10.5217\/ir.2020.00008","journal-title":"Intest Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv195","article-title":"Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow-up study","volume":"10","author":"van Erp SJ","year":"2016","unstructured":"van Erp SJ, Brakenhoff LK, van Gaalen FA, et al.. Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow-up study. J Crohns Colitis. 2016, 10:166-75. 10.1093\/ecco-jcc\/jjv195","journal-title":"J Crohns Colitis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.02.010","article-title":"Antibiotic exposure and risk of new-onset inflammatory bowel disease: a systematic review and dose-response meta-analysis","volume":"23","author":"Duan R","year":"2025","unstructured":"Duan R, Zhang C, Li G, Li J, Duan L. Antibiotic exposure and risk of new-onset inflammatory bowel disease: a systematic review and dose-response meta-analysis. Clin Gastroenterol Hepatol. 2025, 23:45-58. 10.1016\/j.cgh.2024.02.010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/diseases13050139","article-title":"Nutrition in inflammatory bowel disease: strategies to improve prognosis and new therapeutic approaches","volume":"13","author":"Bueno-Hern\u00e1ndez N","year":"2025","unstructured":"Bueno-Hern\u00e1ndez N, Yamamoto-Furusho JK, Mendoza-Mart\u00ednez VM. Nutrition in inflammatory bowel disease: strategies to improve prognosis and new therapeutic approaches. Diseases. 2025, 13:139. 10.3390\/diseases13050139","journal-title":"Diseases"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.12.009","article-title":"Nutritional regulation of microbiota-derived metabolites: implications for immunity and inflammation","volume":"57","author":"Arifuzzaman M","year":"2024","unstructured":"Arifuzzaman M, Collins N, Guo CJ, Artis D. Nutritional regulation of microbiota-derived metabolites: implications for immunity and inflammation. Immunity. 2024, 57:14-27. 10.1016\/j.immuni.2023.12.009","journal-title":"Immunity"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01932-2","article-title":"Inflammation accelerating intestinal fibrosis: from mechanism to clinic","volume":"29","author":"Xin S","year":"2024","unstructured":"Xin S, Liu X, He C, et al.. Inflammation accelerating intestinal fibrosis: from mechanism to clinic. Eur J Med Res. 2024, 29:335. 10.1186\/s40001-024-01932-2","journal-title":"Eur J Med Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system","volume":"24","author":"Saez A","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system. Int J Mol Sci. 2023, 24:1526. 10.3390\/ijms24021526","journal-title":"Int J Mol Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.288","article-title":"Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease","volume":"162","author":"Abraham C","year":"2022","unstructured":"Abraham C, Abreu MT, Turner JR. Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease. Gastroenterology. 2022, 162:1602-16. 10.1053\/j.gastro.2021.12.288","journal-title":"Gastroenterology"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/apt.70162","article-title":"Increased risk of cardiovascular events after coronary interventions in inflammatory bowel disease: a Nationwide Matched Cohort Study","volume":"61","author":"Ebrahimi R","year":"2025","unstructured":"Ebrahimi R, Ebrahimi F, Niess JH, et al.. Increased risk of cardiovascular events after coronary interventions in inflammatory bowel disease: a Nationwide Matched Cohort Study. Aliment Pharmacol Ther. 2025, 61:1904-12. 10.1111\/apt.70162","journal-title":"Aliment Pharmacol Ther"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-024-05468-9","article-title":"Risk of atrial fibrillation development in adolescent patients with inflammatory bowel disease","volume":"183","author":"El Amrousy D","year":"2024","unstructured":"El Amrousy D, El Ashry H, Maher S, Hamza M, Hasan S. Risk of atrial fibrillation development in adolescent patients with inflammatory bowel disease. Eur J Pediatr. 2024, 183:1917-23. 10.1007\/s00431-024-05468-9","journal-title":"Eur J Pediatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.03.021","article-title":"Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies","volume":"173","author":"Liu M","year":"2021","unstructured":"Liu M, de Juan Abad BL, Cheng K. Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies. Adv Drug Deliv Rev. 2021, 173:504-19. 10.1016\/j.addr.2021.03.021","journal-title":"Adv Drug Deliv Rev"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000504","article-title":"Mechanisms underlying dysregulation of electrolyte absorption in inflammatory bowel disease-associated diarrhea","volume":"21","author":"Priyamvada S","year":"2015","unstructured":"Priyamvada S, Gomes R, Gill RK, Saksena S, Alrefai WA, Dudeja PK. Mechanisms underlying dysregulation of electrolyte absorption in inflammatory bowel disease-associated diarrhea. Inflamm Bowel Dis. 2015, 21:2926-35. 10.1097\/MIB.0000000000000504","journal-title":"Inflamm Bowel Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.686778","article-title":"Iron deficiency anemia in inflammatory bowel disease: what do we know?","volume":"8","author":"Res\u00e1l T","year":"2021","unstructured":"Res\u00e1l T, Farkas K, Moln\u00e1r T. Iron deficiency anemia in inflammatory bowel disease: what do we know?. Front Med (Lausanne). 2021, 8:686778. 10.3389\/fmed.2021.686778","journal-title":"Front Med (Lausanne)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v15.i11.553","article-title":"Cardiovascular implications of inflammatory bowel disease: an updated review","volume":"15","author":"Bhardwaj A","year":"2023","unstructured":"Bhardwaj A, Singh A, Midha V, Sood A, Wander GS, Mohan B, Batta A. Cardiovascular implications of inflammatory bowel disease: an updated review. World J Cardiol. 2023, 15:553-70. 10.4330\/wjc.v15.i11.553","journal-title":"World J Cardiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/jpm15090418","article-title":"Cardiovascular complications are increased in inflammatory bowel disease: a path toward achievement of a personalized risk estimation","volume":"15","author":"Annese V","year":"2025","unstructured":"Annese V, Annunziata ML, Petroni GA, et al.. Cardiovascular complications are increased in inflammatory bowel disease: a path toward achievement of a personalized risk estimation. J Pers Med. 2025, 15:418. 10.3390\/jpm15090418","journal-title":"J Pers Med"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/17562848241299534","article-title":"Inflammatory bowel disease and cardiac function: a systematic review of literature with meta-analysis","volume":"17","author":"Soares CA","year":"2024","unstructured":"Soares CA, Fiuza JG, Rodrigues CA, et al.. Inflammatory bowel disease and cardiac function: a systematic review of literature with meta-analysis. Therap Adv Gastroenterol. 2024, 17:17562848241299534. 10.1177\/17562848241299534","journal-title":"Therap Adv Gastroenterol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.14740\/jmc4104","article-title":"Myocarditis related to the use of mesalazine","volume":"14","author":"Kyriakou M","year":"2023","unstructured":"Kyriakou M, Sakellaropoulos S, Constantinides T, Chatzantonis G, Avraamides P, Mitsis A. Myocarditis related to the use of mesalazine. J Med Cases. 2023, 14:237-43. 10.14740\/jmc4104","journal-title":"J Med Cases"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.00026","article-title":"Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia","volume":"17","author":"Ooi CJ","year":"2019","unstructured":"Ooi CJ, Hilmi I, Banerjee R, et al.. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia. Intest Res. 2019, 17:285-310. 10.5217\/ir.2019.00026","journal-title":"Intest Res"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2455536","article-title":"Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis","volume":"57","author":"Yang H","year":"2025","unstructured":"Yang H, An T, Zhao Y, Shi X, Wang B, Zhang Q. Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis. Ann Med. 2025, 57:2455536. 10.1080\/07853890.2025.2455536","journal-title":"Ann Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14186476","article-title":"The cardiovascular effects of inflammatory bowel disease therapy with biologics and small molecules: a comprehensive review","volume":"14","author":"Mastoridou EM","year":"2025","unstructured":"Mastoridou EM, Fousekis FS, Sakellariou XM, et al.. The cardiovascular effects of inflammatory bowel disease therapy with biologics and small molecules: a comprehensive review. J Clin Med. 2025, 14:6476. 10.3390\/jcm14186476","journal-title":"J Clin Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65136","article-title":"Inflammatory bowel disease and cardiovascular disease: an integrative review with a focus on the gut microbiome","volume":"16","author":"Cruz CS","year":"2024","unstructured":"Cruz CS, Huerta AR, Barrientos JL, et al.. Inflammatory bowel disease and cardiovascular disease: an integrative review with a focus on the gut microbiome. Cureus. 2024, 16:e65136. 10.7759\/cureus.65136","journal-title":"Cureus"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.5493\/wjem.v12.i1.1","article-title":"New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease","volume":"12","author":"Pascoal LB","year":"2022","unstructured":"Pascoal LB, Palma BB, Chaim FH, et al.. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med. 2022, 12:1-15. 10.5493\/wjem.v12.i1.1","journal-title":"World J Exp Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S379874","article-title":"A heart-healthy diet for cardiovascular disease prevention: where are we now?","volume":"19","author":"Diab A","year":"2023","unstructured":"Diab A, Dastmalchi LN, Gulati M, Michos ED. A heart-healthy diet for cardiovascular disease prevention: where are we now?. Vasc Health Risk Manag. 2023, 19:237-53. 10.2147\/VHRM.S379874","journal-title":"Vasc Health Risk Manag"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03154-2","article-title":"Management of atherosclerotic cardiovascular risk in inflammatory bowel disease: current perspectives","volume":"42","author":"Masson W","year":"2025","unstructured":"Masson W, Fern\u00e1ndez-Villar G, Martinez-Elhelou S. Management of atherosclerotic cardiovascular risk in inflammatory bowel disease: current perspectives. Adv Ther. 2025, 42:2118-34. 10.1007\/s12325-025-03154-2","journal-title":"Adv Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/439836-arrhythmogenic-implications-of-inflammatory-bowel-disease-its-mechanisms-and-treatment-effects","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:52:12Z","timestamp":1766037132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/439836-arrhythmogenic-implications-of-inflammatory-bowel-disease-its-mechanisms-and-treatment-effects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.99503","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}